Cargando…
Pre-Clinical Efficacy and Safety of Experimental Vaccines Based on Non-Replicating Vaccinia Vectors against Yellow Fever
BACKGROUND: Currently existing yellow fever (YF) vaccines are based on the live attenuated yellow fever virus 17D strain (YFV-17D). Although, a good safety profile was historically attributed to the 17D vaccine, serious adverse events have been reported, making the development of a safer, more moder...
Autores principales: | Schäfer, Birgit, Holzer, Georg W., Joachimsthaler, Alexandra, Coulibaly, Sogue, Schwendinger, Michael, Crowe, Brian A., Kreil, Thomas R., Barrett, P. Noel, Falkner, Falko G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170363/ https://www.ncbi.nlm.nih.gov/pubmed/21931732 http://dx.doi.org/10.1371/journal.pone.0024505 |
Ejemplares similares
-
Vectors Based on Modified Vaccinia Ankara Expressing Influenza H5N1 Hemagglutinin Induce Substantial Cross-Clade Protective Immunity
por: Hessel, Annett, et al.
Publicado: (2011) -
A Pandemic Influenza H1N1 Live Vaccine Based on Modified Vaccinia Ankara Is Highly Immunogenic and Protects Mice in Active and Passive Immunizations
por: Hessel, Annett, et al.
Publicado: (2010) -
MVA Vectors Expressing Conserved Influenza Proteins Protect Mice against Lethal Challenge with H5N1, H9N2 and H7N1 Viruses
por: Hessel, Annett, et al.
Publicado: (2014) -
Selection of recombinant MVA by rescue of the essential D4R gene
por: Ricci, Patricia S, et al.
Publicado: (2011) -
Development of an In Vitro Biopotency Assay for an AAV8 Hemophilia B Gene Therapy Vector Suitable for Clinical Product Release
por: Lengler, Johannes, et al.
Publicado: (2020)